| CAS: | 5302-45-4 | |||||||||||
| 分子式: | C5H8N2O5 | |||||||||||
| 分子量: | 176.12 | |||||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||
| O861333 | MACKLIN | 3-[(羧基羰基)氨基]-L-丙氨酸 | 分析对照品,98% | 1100元/20mg; 3799元/100mg; 15196元/500mg; | 咨询 | ||||||||||||||||||||||||||||||||||||
储存:2-8ºC 状态:白色到米黄色粉末 | |||||||||||||||||||||||||||||||||||||||||
| O761900 | MACKLIN | 3-[(羧基羰基)氨基]-L-丙氨酸 | 10mM in DMSO | 980元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||
储存:-20°C, 避光 | |||||||||||||||||||||||||||||||||||||||||
| 800720 | J&K | Dencichine | 98% | 1200元/20MG; | 咨询 | ||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||
| SML1836 | Sigma-Aldrich | β-ODAP | ≥98% (HPLC) | 1562.86元/5 MG; 6299.25元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 β-ODAP 是一种强效的 HIF 脯氨酰羟化酶-2 (PHD-2) 抑制剂,在常氧条件下可诱导 HIF 依赖性的 HRE (hypoxia response element)。β-ODAP 是一种谷氨酸的类似物,存在于小黧豆(草豌豆)中,它激活 AMPA 受体。在长期食用小黧豆种子的情况下,β-ODAP 会导致神经发育不良。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||
| HY-N1477 | MCE | Dencichine,5302-45-4,三七素_MCE(MedChemExpress) | 1815元/10 mM * 1 mL in DMSO; 1650元/5 mg; 2650元/10 mg; 4770元/25 mg; | 咨询 | |||||||||||||||||||||||||||||||||||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 DencichineMCE 国际站:Dencichine 品牌:MedChemExpress (MCE) 货号:HY-N1477 CAS 号:5302-45-4 生物活性:丹西辛是一种非蛋白质氨基酸,最初提取自三七,可抑制 HIF-脯氨酰羟化酶-2 (PHD-2) 的活性。 体外研究(In Vitro):Dencichin (β-ODAP, 10 μM, 50 μM, 100 μM and 200 μM) increases HRE expression by 1.3±0.09, 2.5±0.07, 4.2±0.15 and 1.3±0.07 fold respectively compared to control. Dencichin has intermolecular interactions with PHD-2[1]. Dencichin (10 μM, 100 μM, 1 mM) significantly inhibits cell proliferation and extracellular matrix (ECM) proteins accumulation of HBZY-1 cells, and reduces the secretion of collagen I (Col I), collagen IV (Col IV), and fibronectin (FN)[2]. MCE尚未独立确认这些方法的准确性。 仅供参考。 体内研究(In Vivo):Dencichin improves metabolism disorder in diabetic nephropathy (DN) secondary to type II diabetes mellitus (DM) model. Dencichin (80, 160 mg/kg/day, p.o.) significantly prevents the up-regulation of TCH, TG, LDL, and HbAlc and the down-regulation of HDL in DN rats induced by STZ injection. Dencichin also attenuates renal injury induced in the DN secondary to type II DM model. Dencichin alleviates pancreas damage in the STZ-induced DN model. Dencichin regulates protein expression in the TGF-β/Smad signalling pathway in STZ-induced DN models[2]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:176.13 Formula:C5H8N2O5 性状:固体 颜色:White to off-white 中文名称:三七素 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:4°C,避光保存 *溶剂保存:-80°C,6个月;-20°C,1个月(避光保存) Cell Assay [2]:将细胞在含有葡萄糖 (LG) 或高葡萄糖对照 (HG) 的 6 孔板中培养,然后用缬沙坦 (1.0 × 10-3 M) 或 Dencichin (1.0 × 10-5 M、1.0 × 10-4 M 和 1.0 × 10-3 M) 处理 24 小时,然后通过 ELISA 分析 FN、Col I 和 Col IV 表达的激活并分析 MMP-9 和免疫荧光检测 TIMP-1 表达。在整个研究过程中每个实验至少重复三次[2]。 MCE 尚未独立确认这些方法的准确性。仅供参考。 Animal Administration [2]:Male SD rats weighted approximately 200 ± 20 g (eight weeks old) are kept at 23 ± 2°C. The rats are randomLy allotted into two groups: normal group (n = 16) and diabetic nephropathy (DN) group (n = 60). The normal rats fed with normal diet and vehicle fall into the normal control group (NC, n = 8) and the normal rats fed with normal diet and Dencichin fall into the Dencichin control group (De C, n = 8). The rats in the diabetic group are fed the high-sugar-high-fat diet (composition: Common breeding material 54.6%, lard oil 16.9%, sucrose 14%, casein 10.2%, gunk 2.1%, maltodextrin 2.2%). Five weeks later, DN is induced by administering of 40 mg/kg STZ though intraperitoneal injection, and the normal rats are treated with vehiclecitrate buffer (0.1 M, pH 4.2). Next, the DN rats (n = 32) are assigned into four groups and oral administered with metformin hydrochloride (a positive control) at 80 mg/kg/day, (DN+Met, n = 8), which is dissolve into distilled water to make a 2 mg/mL solution before use; vehicle control for the DN control group (DN, n = 8), or Dencichin. The Dencichin group is divided into a high Dencichin group (160 mg/kg/day; DN+De H, n = 8) and a low Dencichin group (80 mg/kg/day; DN+De L, n = 8), which are dissolved into distilled water to make a 5 mg/mL and 2.5 mg/mL solution before use and oral administered at the dosage once per day. Blood glucose is measured each month. 8 w after administering with Dencichin, the rats are killed[2]. MCE尚未独立确认这些方法的准确性。 仅供参考。 提供质量检测报告:Data Sheet、SDS、COA、HNMR、RP-HPLC、MS、产品使用指南 产品活性:Dencichin 是从三七中分到的非蛋白氨基酸,能够抑制 HIF-prolyl hydroxylase-2 (PHD-2) 的活性。 IC50 & Target:PHD-2[1] 相关产品:IBMX | IBMX | Roxadustat | Roxadustat (Standard) | IBMX (Standard) | Molidustat | 2-Ketoglutaric acid | Sorafenib | XAV-939 | Lovastatin | 2-Ketoglutaric acid (Standard) | Vadadustat 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||||||||||||||||||||||||||||||||||||